Monday, March 23, 2020 10:59:20 AM
Here is the only notable takeaway:
>>>"finalized the configuration" -- per the earlier PR's the configuration had already been finalized and DECN was hoping to gain access to the infected Korean blood samples for testing. Hmmmm....?
>>>"will go into production" -- where? DECN does not have a commercial manufacturing facility.
>>>"product testing" -- not mentioned!!!
>>>"as soon as the FDA grants emergency status" -- it ain't gonna happen without a substantial amount of valid test data, which will take time to produce and summarize. Keep in mind, per Berman, the product configuration has just been finalized!
It appears CEO Keith Berman is the "Master of Headlines", but the actual meat is lacking!
BTW, the PR very clearly documents the FACT the DECN blood testing technology is NOT included as a part of the FDA EUA Guidelines. Per the FDA mandate, Mr. Berman should hookup with the FDA to "discuss" it!
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM